|
Identification of homologous recombination and repair (HRR) deficiency using circulating tumor DNA (ctDNA) in advanced prostate cancer (aPC). |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
|
|
No Relationships to Disclose |
|
|
Employment - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Patent for MSI c |